BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19838435)

  • 21. Ocular vascular thrombotic events: a diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis.
    Glueck CJ; Wang P
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):12-8. PubMed ID: 18796459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasminogen activator inhibitor type 1 activity in women with unexplained very early recurrent pregnancy loss].
    Ivanov P; Komsa-Penkova R; Ivanov I; Konova E; Kovacheva K; Simeonova M; Tanchev S
    Akush Ginekol (Sofiia); 2010; 49(5):3-8. PubMed ID: 21268395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic determinants of hereditary thrombophilia in pathogenesis of venous thrombosis].
    Kapustin SI; Blinov MN; Kargin VD; Filanovskaia LI; Saltykova NB; Beliazo OE; Golovina OG; Shmeleva VM; Panshina AM; Papaian LP
    Ter Arkh; 2003; 75(10):78-80. PubMed ID: 14669613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications.
    Glueck CJ; Phillips H; Cameron D; Wang P; Fontaine RN; Moore SK; Sieve-Smith L; Tracy T
    Metabolism; 2000 Jul; 49(7):845-52. PubMed ID: 10909993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A boy with venous thrombosis, homozygous for factor V Leiden, prothrombin G20210A and MTHFR C667t mutations, but belonging to an asymptomatic family.
    Soria JM; Quintana R; Vallvé C; Iruin G; Cortés C; Fontcuberta J
    Haematologica; 2000 Nov; 85(11):1230-2. PubMed ID: 11064483
    [No Abstract]   [Full Text] [Related]  

  • 28. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency.
    Zöller B; García de Frutos P; Dahlbäck B
    Thromb Haemost; 1998 Apr; 79(4):802-7. PubMed ID: 9569196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism in methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and apolipoprotein E in hemodialysis patients.
    Al-Muhanna F; Al-Mueilo S; Al-Ali A; Larbi E; Rubaish A; Abdulmohsen MF; Al-Zahrani A; Al-Ateeq S
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):937-41. PubMed ID: 18974580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombophilia in infancy: factor V Leiden and MTHFR or factor II double heterozygocity as a risk factor.
    Koren A; Levin C; Hujirat Y; El-Hasid R; Kutai M; Lanir N; Shalev S; Brenner B
    Pediatr Hematol Oncol; 2003; 20(3):219-27. PubMed ID: 12637218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A; Egin Y; Cam R; Akar N
    Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of genomic polymorphisms associated with venous thrombosis using the invader biplex assay.
    Patnaik M; Dlott JS; Fontaine RN; Subbiah MT; Hessner MJ; Joyner KA; Ledford MR; Lau EC; Moehlenkamp C; Amos J; Zhang B; Williams TM
    J Mol Diagn; 2004 May; 6(2):137-44. PubMed ID: 15096570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between polymorphisms in thrombophilic genes and preeclampsia in a Brazilian population.
    Dalmáz CA; Santos KG; Botton MR; Tedoldi CL; Roisenberg I
    Blood Cells Mol Dis; 2006; 37(2):107-10. PubMed ID: 16963292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults.
    Balasa VV; Gruppo RA; Glueck CJ; Stroop D; Becker A; Pillow A; Wang P
    Thromb Haemost; 1999 May; 81(5):739-44. PubMed ID: 10365747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
    Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
    Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor V Leiden, prothrombin 20210G --> A, methylenetetrahydrofolate reductase 677C --> T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism.
    Meglic L; Stegnar M; Milanez T; Bozic M; Peterlin B; Peternel P; Novak-Antolic Z
    Eur J Obstet Gynecol Reprod Biol; 2003 Dec; 111(2):157-63. PubMed ID: 14597244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
    Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MTHFR C 677T mutation and 4G/5G PAI-1 polymorphism in patient with polycystic ovarian syndrome.
    Radaković B; Goldstajn MS
    Coll Antropol; 2007 Sep; 31(3):919-21. PubMed ID: 18041407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic thrombophilias and preeclampsia: a meta-analysis.
    Lin J; August P
    Obstet Gynecol; 2005 Jan; 105(1):182-92. PubMed ID: 15625161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.